CD44 and hepatocellular carcinoma: Among these surface markers, detection of the expression levels of circulating CD44 splice variant (CD44v) mRNA molecules in blood samples from patients with HCC can be used as an adjuvant method of predicting and monitoring HCC recurrence [44].